Clinical Trial Update: COMMIT (Combination Of Maintenance Methotrexate-Infliximab Trial) [Phase 3]

View source ↗

Summary

Phase 3 COMMIT trial evaluating maintenance therapy with methotrexate and infliximab in Crohn's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• Remicade (infliximab)

Snippet

Sponsor: University of Western Ontario, Canada | Conditions: Crohn's Disease | Phase 3 | Status: COMPLETED